NCT05234606 A Safety and Preliminary Efficacy Study of SBT6290 Alone and in Combination With PD-(L)1 Inhibitors in Select Advanced Solid Tumors Status WITHDRAWN Phase PHASE1/PHASE2
NCT05230888 Comprehensive Geriatric Assessment in Elderly Non-Small Cell Lung Cancer Patients Status WITHDRAWN Phase N/A
NCT05226728 Pharmacokinetically-guided on the Individualization of Pembrolizumab Administration in the Treatment of Lung Cancer Status COMPLETED Phase PHASE1
NCT05221840 A Global Study to Assess the Effects of Durvalumab With Oleclumab or Durvalumab With Monalizumab Following Concurrent Chemoradiation in Patients With Stage III Unresectable Non-Small Cell Lung Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05218759 Exosomes Detection for the Prediction of the Efficacy and Adverse Reactions of Anlotinib in Patients With Advanced NSCLC Status NOT_YET_RECRUITING Phase NA
NCT05215574 Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05211895 A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC Status RECRUITING Phase PHASE3
NCT05210946 A Single-Arm Clinical Study of Pemigatinib in the Treatment of Advanced Non-Small Cell Lung Cancer Patients Status UNKNOWN Phase NA
NCT05204628 A Study to Evaluate and Compare the Efficacy and Safety of XZP-3621 Versus Crizotinib Status UNKNOWN Phase PHASE3
NCT05195632 Phase II Study Investigating the Combination of Encorafenib and Binimetinib in BRAF V600E Mutated Chinese Patients With Metastatic Non-Small Cell Lung Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05195619 Personalized DC Vaccines in Non Small Cell Lung Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05194735 Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors Status TERMINATED Phase PHASE1/PHASE2
NCT05186974 Study of Sacituzumab Govitecan Combinations in First-line Treatment of Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05186506 A Study Comparing Ensatinib Versus Platinum-Based Chemotherapy as Adjuvant Treatment for Stage II-IIIA ALK -Positive Non-Small Cell Lung Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT05183932 Surgery Versus Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05183243 GH21 Capsules for Advanced Solid Tumors: A Study on Safety and Early Results Status RECRUITING Phase PHASE1
NCT05176925 Tislelizumab Combined With Sitravatinib as Consolidation Treatment Following Concurrent Chemoradiation in Patients With Locally Advanced, Unresectable NSCLC Status TERMINATED Phase PHASE2
NCT05172739 Opioid Free Anaesthesia-Analgesia Strategy on Surgical Stress and Immunomodulation in Elective VATS-Lobectomy for NSCLC Status RECRUITING Phase PHASE4